Category: Replacement Heart ValvesSyndicate content

Heart Valves

Medtronic reports positive CoreValve data

October 15, 2014 by Alexander Soule

Medtronic reports positive data from a study evaluating an alternative implantation procedure for its CoreValve aortic valve-replacement device.

Medtronic reports positive CoreValve data

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

FDA panel recommends PMA process for CryoLife heart valve

October 10, 2014 by Brad Perriello

An FDA advisory panel recommends that CryoLife's heart valve, the CryoValve allograft, be subject to its most-stringent pre-market approval protocol.

FDA panel recommends PMA process for CryoLife heart valve

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Sorin announces first U.S. implant of Solo Smart heart valve

October 10, 2014 by Alexander Soule

Sorin announces the first U.S. implant of its recently approved Solo Smart aortic heart valve.

Sorin announces first U.S. implant of Solo Smart heart valve

Sorin Group (BIT:SRN) said that a patient in Indianapolis was the first U.S. recipient of its recently approved Solo Smart aortic heart valve.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

TAVI: Claret Medical launches U.S. trial

October 6, 2014 by Alexander Soule

Claret Medical launches a pivotal U.S. trial for its Sentinel cerebral protection system, which is designed to guard against stroke during transcatheter aortic valve implantation.

TAVI: Claret Medical launches U.S. trial

Claret Medical said today that the 1st patient has been treated in a U.S. pivotal trial of its Sentinel cerebral protection system, which is designed to guard against stroke during transcatheter aortic valve implantation.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Wall Street loves Edwards Lifesciences again

October 3, 2014 by Brian Johnson

Edwards Lifesciences is flirting with all time highs on The Street after nearly 2 years of bearish results.

Edwards: Medtronic TAVI settlement boosts bottom line in Q2

Edwards Lifesciences (NYSE:EW) is back in Wall Street's good graces, with shares of the Irvine, Calif.-based heart valve maker approaching all time highs after nearly 2 years of down performance.

TAVI: Direct Flow Medical wins CE Mark for enhanced heart valve delivery device

October 2, 2014 by Alex Soule

Direct Flow Medical chalks up CE Mark approval in the European Union for an enhanced delivery system for its transcatheter aortic valve implant.

TAVI: Direct Flow Medical wins CE Mark for enhanced heart valve delivery device

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Analyst: Edwards Lifesciences' Sapien 3 poised to lead TAVI market | MassDevice.com On Call

October 2, 2014 by Brad Perriello

The Sapien 3 replacement heart valve made by Edwards Lifesciences is poised to take the lead in the market for transcatheter aortic valve implants, according to one analyst.

MassDevice.com On Call

MASSDEVICE ON CALL — Edwards Lifesciences (NYSE:EW) is poised to take the lead in the transcatheter aortic valve market with its Sapient 3 replacement heart valve, according to Leerink Partners analyst Danielle Antalffy.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp